Literature DB >> 31840661

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice.

Ri Youn Kim1, Ju Hee Lee2, Yena Oh1, Hoon-Ki Sung3, Kyoung-Han Kim4.   

Abstract

Intermittent fasting (IF), a dietary intervention involving periodic energy restriction, has been considered to provide numerous benefits and counteract metabolic abnormalities. So far, different types of IF models with varying durations of fasting and feeding periods have been documented. However, interpreting the outcomes is challenging, as many of these models involve multifactorial contributions from both time- and calorie-restriction strategies. For example, the alternate day fasting model, often used as a rodent IF regimen, can result in underfeeding, suggesting that health benefits from this intervention are likely mediated via both caloric restriction and fasting-refeeding cycles. Recently, it has been successfully demonstrated that 2:1 IF, comprising 1 day of fasting followed by 2 days of feeding, can provide protection against diet-induced obesity and metabolic improvements without a reduction in overall caloric intake. Presented here is a protocol of this isocaloric 2:1 IF intervention in mice. Also described is a pair-feeding (PF) protocol required to examine a mouse model with altered eating behaviors, such as hyperphagia. Using the 2:1 IF regimen, it is demonstrated that isocaloric IF leads to reduced body weight gain, improved glucose homeostasis, and elevated energy expenditure. Thus, this regimen may be useful to investigate the health impacts of IF on various disease conditions.

Entities:  

Mesh:

Year:  2019        PMID: 31840661     DOI: 10.3791/60174

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

Review 1.  Intermittent Fasting: Potential Bridge of Obesity and Diabetes to Health?

Authors:  Bo-Ying Zang; Li-Xia He; Ling Xue
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

2.  Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.

Authors:  Shaza Asif; Ri Youn Kim; Thet Fatica; Jordan Sim; Xiaoling Zhao; Yena Oh; Alix Denoncourt; Angela C Cheung; Michael Downey; Erin E Mulvihill; Kyoung-Han Kim
Journal:  Mol Metab       Date:  2022-04-12       Impact factor: 8.568

Review 3.  Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases.

Authors:  Shaza Asif; Nadya M Morrow; Erin E Mulvihill; Kyoung-Han Kim
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.